Haibo Shao
Clinical trials sponsored by Haibo Shao, explained in plain language.
-
New quadruple therapy aims to control liver cancer in diabetic patients
Disease control Not yet recruitingThis study tests a combination of four drugs (epalrestat, liver-directed chemotherapy, donafenib, and tislelizumab) as a first treatment for people with advanced liver cancer that cannot be removed by surgery and who also have diabetes. The goal is to see if this mix can stop the…
Phase: PHASE2 • Sponsor: Haibo Shao • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New technique may boost lung cancer cryoablation success
Disease control Not yet recruitingThis study tests a new approach for lung cancer patients at high risk of incomplete tumor freezing during cryoablation. Before the freezing procedure, doctors will block small lung arteries with a temporary, absorbable material to improve the freezing effect and reduce bleeding r…
Phase: NA • Sponsor: Haibo Shao • Aim: Disease control
Last updated May 20, 2026 11:54 UTC